Home Neoplasma 2019 Neoplasma Vol.66, No.6, p.971–977, 2019

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.66, No.6, p.971–977, 2019

Title: Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients
Author: X. L .Li, Z. H. Yao, Y. Y. Wan, X. Y. Mou, Y. H. Ni, E. L. Sun, D. Zang , D. J. Lin

Abstract: Prognostic nutritional index (PNI) is a parameter reflecting prognosis for various cancers, including resected lung cancer. However, there were few reports to study the relationship between the PNI and overall survival (OS) in patients with advanced (stage IIIB/IV) non-small lung cancer (NSCLC). In this study, we collected the clinical data of 315 patients with advanced (stage IIIB/IV) NSCLC who had received chemotherapy or epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) between January 2010 and June 2011. Survival curves were plotted using the Kaplan-Meier method. Multivariate analyses were used to evaluate prognostic significance of PNI in patients with advanced (stage IIIB/IV) NSCLC. In our analysis, we found that PNI (p=0.001) was significantly associated with OS in patients with advanced (stage IIIB/IV) NSCLC, so was smoking (p

Keywords: non-small cell lung cancer, prognostic nutritional index, prognosis
Published online: 07-Aug-2019
Year: 2019, Volume: 66, Issue: 6 Page From: 971, Page To: 977
doi:10.4149/neo_2019_190125N76
Price: 14.70 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.